国务院联防联控机制权威发布(2020年3月17日)_中国政府网
https://player.v.news.cn/api/v1/getPlayPage?uuid=1_2bc71bd967c24646b05c3b608b6a3a6f&vid=d961b3c602ebe9ce3f7f6e673a93af98&playType=0 国务院联防联控机制3月17日15时在北京国二招
https://player.v.news.cn/api/v1/getPlayPage?uuid=1_2bc71bd967c24646b05c3b608b6a3a6f&vid=d961b3c602ebe9ce3f7f6e673a93af98&playType=0 国务院联防联控机制3月17日15时在北京国二招
無法取得資料
SEOUL, March 16 (Yonhap) -- South Korea will not use Japan's anti-influenza medication, called Avigan, for the treatment of the novel coronavirus due to doubts over its efficacy and potential side eff
Ciclesonide (marketed as Alvesco), which has been used as a new treatment against the novel coronavirus, is seen in this photo from the website of Teijin Pharma Ltd. The development of methods
Patients given the medicine in Shenzhen turned negative in a median of four days Photograph: John Minchillo/AP Medical authorities in China have said a drug used in Japan to treat new strains of in
以上內容由「Cofacts 真的假的」訊息回報機器人與查證協作社群提供,以 CC授權 姓名標示-相同方式分享 4.0 (CC BY-SA 4.0) 釋出,於後續重製或散布時,原社群顯名及每一則查證的出處連結皆必須被完整引用。